AJA Asian Journal of Anesthesiology

Advancing, Capability, Improving lives

Research Paper
Volume 53, Issue 2, Pages 58-61
Shiu-Yu C. Lee 1 , Cheng-Hsu Wang 2
505 Views


Abstract

Pain is a burdensome symptom that can commonly exist chronically along the cancer trajectory. Uncontrolled pain will impact on cancer patients' quality of life, even further negatively affect cancer survivors' employment. Based on systemic reviews of studies for past 10 years, the paper reported that although there is enormous advancement on the knowledge of cancer pain and pain management, studies still documented undertreatment of cancer pain globally. Additionally, pain distress a significant portion of cancer survivors. The pain in cancer survivors distinct from the pain related with cancer, instead emphasize on pain related with cancer treatment, such as neuropathic pain, muscular syndrome. Evidence-based pain management with common pain problems in cancer survivors is lacking. Further studies are needed to understand the pain in cancer survivors and to develop effective strategies in helping cancer survivors to manage their pain.

Keywords

cancer paincancer survivorprevalencepain management;


1. Undertreatment of cancer pain

Pain is one of the most distressed symptom in patients with cancer. With the analgesic ladder by the WHO in 1986, a majority of cancer patients would have their pain being controlled. Zech1 reported that the practice by the WHO analgesic ladder have led to 76% of the patients in their study had good pain relief over the whole treatment period, with 12% rate of inadequate efficacy. However, uncontrolled cancer pain was destructive and costly. Studies supported that unaddressed cancer pain can lead to poor quality of life, greater depression, poor function, poor sleep and more distressed symptom.234 Many unscheduled emergency visits (27.8%) was because of uncontrolled pain and almost 10% of them re-admitted within 72 hours.5 Uncontrolled pain may further influence the employment status in cancer survivors.6

There is a vast progress in the control of either acute or chronic cancer pain for the past 50 years. In the early 1970s, cancer pain management was still in its infancy. Along with the WHO's analgesic ladder, the American Pain Society7 has provided recommendation of assessment and developed quality indicators for monitoring and improving the quality of the cancer pain management, which has been widely endorsed around the world. As the advanced knowledge of cancer pain and treatment, more guidelines were published and recommended more specifically about the choices of opioids and routes of administration, titration, non-pharmacological intervention and management for adverse effect.8910 There also have been aggressive initiatives to improve the care for cancer pain in recent two decades, including that the Joint Commission on Accreditation of Healthcare Organizations in USA enacted pain assessment and management as one of standards and to be part of the survey and accreditation process for all organizations providing direct care,11 as well as the Ministry of Health in Taiwan did in 2005.12 The introduction of pain management standards is expected to improve the quality of pain management.

Although many striking efforts are made to improve the quality of pain management, and studies have demonstrated the effect of the pain communication,13 advanced procedure,14 patient education15 and psychosocial intervention16 on cancer pain control, the pain in cancer patients remain undertreated.31718 Pain was identified as the most common problem (27.8%) that was presented by the cancer patients visiting the emergency department in northern Taiwan.19 The inadequate pain management as measured by negative Pain Management Index (PMI) were also reported by Mitera20 with 25% in patients with pain related to bone metastasis, and by Fisch21 with 33% in patients with pain related to various cancer diagnosis and receiving care in ambulatory setting.

The inadequate pain control or undertreated pain in cancer patients remains a global issue. The Institute of Medicine reported that 50% of cancer patients around the world had pain.22 In USA, Weingart23 examined the quality of cancer pain care and reported that among advanced cancer patients with severe pain, 34% of patients continued to report severe pain a month after the visit. In Italy, 40.3% of cancer patient with pain had breakthrough pain, but most of them being untreated did not.24 In Japan, patients with non-advanced cancer or the cancer with no evidence of any recurrence tended to receive inadequate treatment than those with advanced cancer25 and around 20% of metastatic or recurrent cancer patients in outpatient clinics had moderate to server pain.26 In Taiwan, Tang's population-based study27 in 1370 terminal cancer patients revealed that 47.4% of the patients were not satisfied with their pain relief within one week of admission and 23.6% had inadequate pain medication. Liang28 found that around 50% of the ambulatory cancer patients in Taipei reported pain most of the time, and only 11% of patients experienced good pain management.

The pain influences the life of cancer patients across the cancer trajectory. Not only is the pain as the major concern of the patient at the end of life,29 but also in those who under cancer treatment30 or after the completion of the cancer treatment.31 Researcher reported that around 40% of 5-year cancer survivors or disease-free cancer patients experienced various degree of pain.3233 Van den Beuken-van Everdingen34 suggested the prevalence rates of cancer pain were 59% in patients under cancer treatment, 33% in those after curative cancer treatment and 64% among those with advance cancer, based on a pool of findings from 54 articles published from 1966 to 2005. Similarly, Lee and colleague35 also found that the cancer survivors with pain was accounted for 44.8% in a sample of 337 random sampled Taiwanese cancer patients who were two to five years since their cancer diagnosis. With the improvement of cancer treatment and cancer care, there is growing cancer survivors worldwide. However, more than one third of this growing population may suffer with pain. It is important to recognize the burden of pain in cancer survivors.

Pain is one of the most burdened problem in cancer survivors. Even though cancer patients have recovered or have been back to the “normal” from the cancer treatment, the pain as result of cancer treatment may still bother him or her after the completion of the treatment. Pain was recognized as the top three important symptoms that the survivors with breast, colon or lung cancer would like to avoid.36 A recent survey of 314 randomly selected survivors who were diagnosed at least two years after their breast, colon-rectal, oral or cervical cancer being diagnosed, 16.3% of them were distressed by pain that demanded to be further managed.37 This study also revealed that the pain severity differed by cancer diagnoses and the group with oral cancer had significant higher prevalence of pain than the other groups. In Green's survey of cancer survivors,2 42.6% of the overall sample with various cancer diagnoses reported pain since their cancer diagnosis. This was the case for breast cancer (58 %), colorectal cancer (41%), lung cancer (56%), multiple myeloma (100%), and prostate (28%). Most of the people in this survey were cancer free or in remission; nevertheless, about one in five were having pain. Another factor is the age. Especially in the elderly cancer survivors with comorbidities, the ones experiencing pain and other distressed symptoms after the cancer treatment had poor physical health.38

Cancer survivors, as defined in accordance with the NCI, survived and lived with the cancer diagnosis from the moment of being diagnosed.39 Cancer survivors may suffered pain from the advanced cancer, such as the abdominal pain from advanced colon cancer or as the result of the curative anti-cancer treatment, such as the pain from the resection of oral cancer or breast cancer. Studies shown that the cancer survivors undergone surgery for their colon-rectal cancer reported to have neuropathic-like pain in leg or abdominal,40 or have more pain at lower-back41 or pelvic pain as compared42 with non-cancer group. Researcher suggested that cancer treatment may cause the change of the abdominal wall and make the survivors more sensitive to the stimuli. At the last, pain related to cancer or cancer treatment shown various types or phenomena in cancer survivors, such as chronic pain, breakthrough pain. Breakthrough pain is a flares pain or exacerbation of pain either spontaneously or in relation to a specific trigger despite adequately control of pain. The prevalence of breakthrough pain was accounted for 40.3% in Gerco's study in Italy.24

Joint pain as related with aromatase inhibitors taken by breast cancer patient is also an influencing factor for the decreased physical activity or for discontinue of aromatase inhibitors. Brown43 reported Breast cancer survivors with musculoskeletal symptoms related to aromatase inhibitor were more likely to reduce physical activity. Aromatase inhibitors are the adjuvant treatment for the post-menopausal women to less their estrogen and prevent the hormone-receptor-positive breast cancer cell growth. However, musculoskeletal symptoms, including bone demineralization with risk of osteoporosis and fracture, arthralgias, and myalgias are common side effect of aromatase inhibitors.44 Studies revealed that the severity of joint pain and joint stiffness predict discontinue of the aromatase inhibitors in women with breast cancer.4546 For some cancer survivors, the cancer burden shifts from the high mortality rate to the issue of the chronic care from the cancer and cancer treatment.

Neuropathic pain is a special type of pain which differs from a common nociceptive pain that was related to a stimulated pain receptor. Nevertheless, neuropathic pain is a consequence of injured peripheral nerves or central nervous system; and patients may experience spontaneous pain or evoked pain. Bennett conducted a systemic review of previous studies and found that the prevalence of pain with a neuropathic mechanism ranged from 18.7% to 21.4% from all 14 studies.47 The proportion of cancer-treatment-related pain was higher in neuropathic pain compared with all types of cancer pain. Neuropathic pain may be related with surgical injury of nerves or with chemotherapy-induced peripheral neuropathies. Neuropathic pain may be experienced in a mix of pain, numbness, tingling, or electric-like sensations48; and it is common that cancer survivors underreport symptoms, as they confuse about the sensation or fear that they may be removed from the treatment.

Pain post operation have been studied extensively; however, the knowledge about the pain experienced after the treatment or the management of it are still limited. Literature revealed that the cancer survivors presented multifaceted needs as manifested from living with their cancer, or as the result of cancer treatment. Apart from the breakthrough pain, there is lack of evidence-based management strategies to help control other types of pain, such as neuropathic pain, joint pain. Especially the neuropathic pain as related to surgical procedure or chemotherapeutic agents, previous study provided low level of evidence.49 Some studies have explored the effect of physical therapy or exercise on the cancer pain; but the result remained inconsistency.505152 In considering its nature of chronic pain and its impact on emotional and psychosocial aspects of the life, future studies are needed to identify more effective treatment.

In conclusion, pain is one of the most burdensome symptoms in cancer patients, notwithstanding the cancer type or stage. Uncontrolled cancer pain have great impact on patients and their family's quality of life. With the vast advanced knowledge of cancer pain and strategies for pain management, the cancer pain remains undertreated. With the improvement of cancer treatment, the cancer survivors are increased; however, the care shifts from the survival to the issue of the chronic care or quality of life as the consequence of the cancer and cancer treatment. But, for those cancer survivors suffering from chronic pain, evidence-based pain management strategies are still limited. As healthcare providers facing the challenge and the uncertainty of growing demand of good pain management in cancer survivors, multidisciplinary team work is recommended.53 In considering its nature of chronic pain, facilitating cancer patient in self-management and goal attainment54 cannot be overstressed. Further research in developing effective strategies in managing cancer pain is needed.

Conflicts of interest

The authors have none to declare.


References

1
D.F. Zech, S. Grond, J. Lynch, D. Hertel, K.A. Lehmann
Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study
Pain, 63 (1995), pp. 65-76
2
C.R. Green, T. Hart-Johnson, D.R. Loeffler
Cancer-related chronic pain: examining quality of life in diverse cancer survivors
Cancer, 117 (2011), pp. 1994-2003
3
G.P. Kurita, U.B. Tange, H. Farholt, et al.
Pain characteristics and management of inpatients admitted to a comprehensive cancer centre: a cross-sectional study
Acta Anaesthesiologica Scandinavica, 57 (2013), pp. 518-525
4
N. Sharma, C.H. Hansen, M. O'Connor, et al.
Sleep problems in cancer patients: prevalence and association with distress and pain
Psycho-Oncology, 21 (2012), pp. 1003-1009
5
S.C. Tsai, L.N. Liu, S.T. Tang, J.C. Chen, M.L. Chen
Cancer pain as the presenting problem in emergency departments: incidence and related factors
Support Care Cancer, 18 (2010), pp. 57-65
6
K. Kenzik, M. Pisu, S.A. Johns, et al.
Unresolved Pain Interference among Colorectal Cancer Survivors: Implications for Patient Care and Outcomes
Pain Med. (2015 Mar 20), 10.1111/pme.12727 [Epub ahead of print]
Article  
7
D.B. Gordon, J.L. Dahl, C. Miaskowski, et al.
American Pain Society Recommendations for Improving the Quality of Acute and Cancer Pain Management: American Pain Society Quality of Care Task Force
Archives of Internal Medicine, 165 (2005), pp. 1574-1580
8
American Society of Anesthesiologists Task Force on Chronic Pain Management, American Society of Regional Anesthesia and Pain Medicine
Practice Guidelines for Chronic Pain Management
Anesthesiology, 112 (2010), pp. 810-833
Article  
9
C.I. Ripamonti, E. Bandieri, F. Roila
Group ObotEGW. Management of cancer pain: ESMO Clinical Practice Guidelines
Annals of Oncology, 22 (2011), pp. vi69-vi77
10
National Comprehensive Cancer Network. Adult cacner pain. Available from URL:http://www.nccn.org/professionals/physician_gls/pdf/pain.pdf [accessed April 15, 2015].
Article  
11
Joint Commission
Clarification to Standard PC.01.02.07. PC.01.02.07
Joint Commission, USA (2014)
Article  
12
Ministry of Health and Welfare T
Regulations for Cancer Care Quality Assurance Measures
Welfare MoHa, Ministry of Health and Welfare, Tapei, Taiwan (2005)
Article  
13
R.L. Street, D.J. Tancredi, C. Slee, et al.
A pathway linking patient participation in cancer consultations to pain control
Psycho-Oncology, 23 (2014), pp. 1111-1117
14
S.E. Brogan, N.B. Winter
Patient-Controlled Intrathecal Analgesia for the Management of Breakthrough Cancer Pain: A Retrospective Review and Commentary
Pain Medicine, 12 (2011), pp. 1758-1768
15
P.-L. Chou, C.-C. Lin
A pain education programme to improve patient satisfaction with cancer pain management: a randomised control trial
Journal of Clinical Nursing, 20 (2011), pp. 1858-1869
16
S. Sheinfeld Gorin, P. Krebs, H. Badr, et al.
Meta-analysis of psychosocial interventions to reduce pain in patients with cancer
Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 30 (2012), pp. 539-547
Article   CrossRef  
17
S.S. Butt, W.L. Tarar, F. Amin, M.Z. Butt
Pain management in cancer patients in tertiary care hospitals
JPMI: Journal of Postgraduate Medical Institute, 27 (2013), pp. 387-391
18
S.O. Stuver, T. Isaac, J.C. Weeks, et al.
Factors Associated With Pain Among Ambulatory Patients With Cancer With Advanced Disease at a Comprehensive Cancer Center
Journal of Oncology Practice, 8 (2012), pp. e17-e23
19
S.-C. Tsai, L.-N. Liu, S.-T. Tang, J.-C. Chen, M.-L. Chen
Cancer pain as the presenting problem in emergency departments: incidence and related factors
Supportive Care in Cancer, 18 (2010), pp. 57-65
20
G. Mitera, A. Fairchild, C. DeAngelis, et al.
A multicenter assessment of the adequacy of cancer pain treatment using the pain management index
Journal of Palliative Medicine, 13 (2010), pp. 589-593
21
M.J. Fisch, J.-W. Lee, M. Weiss, et al.
Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate Cancer
Journal of Clinical Oncology, 30 (2012), pp. 1980-1988
22
Committee on Advancing Pain Research C, and Education; Institute of Medicine Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, The National Academies Press (2011)
Article  
23
S.N. Weingart, A. Cleary, S.O. Stuver, et al.
Assessing the quality of pain care in ambulatory patients with advanced stage cancer
J Pain Symptom Manage, 43 (2012), pp. 1072-1081
24
M.T. Greco, O. Corli, M. Montanari, S. Deandrea, V. Zagonel, G. Apolone
Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group
Clin J Pain, 27 (2011), pp. 9-18
25
T. Okuyama, X.S. Wang, T. Akechi, et al.
Adequacy of Cancer Pain Management in a Japanese Cancer Hospital
Japanese Journal Of Clinical Oncology, 34 (2004), pp. 37-42
26
A. Yamagishi, T. Morita, M. Miyashita, et al.
Pain intensity, quality of life, quality of palliative care, and satisfaction in outpatients with metastatic or recurrent cancer: a Japanese, nationwide, region-based, multicenter survey
J Pain Symptom Manage, 43 (2012), pp. 503-514
27
S.T. Tang, W.R. Tang, T.W. Liu, C.P. Lin, J.S. Chen
What really matters in pain management for terminally ill cancer patients in Taiwan
J Palliat Care, 26 (2010), pp. 151-158
28
S.Y. Liang, C.C. Li, S.F. Wu, T.J. Wang, S.L. Tsay
The prevalence and impact of pain among Taiwanese oncology outpatients
Pain Manag Nurs, 12 (2011), pp. 197-205
29
R. Adam, P. Murchie
Why are we not controlling cancer pain adequately in the community?
(2014)
Article  
30
H.H. Yin, M.M.Y. Tse, F.K.Y. Wong
Postoperative pain experience and barriers to pain management in Chinese adult patients undergoing thoracic surgery
Journal of Clinical Nursing, 21 (2012), pp. 1232-1243
31
I. Cantarero-Villanueva, C. FernÁNdez-Lao, C. FernÁNdez-De-Las-PeÑAs, L. DÍAz-RodrÍGuez, E. Sanchez-Cantalejo, M. Arroyo-Morales
Associations among musculoskeletal impairments, depression, body image and fatigue in breast cancer survivors within the first year after treatment
European Journal of Cancer Care, 20 (2011), pp. 632-639
32
K.O. Anderson, S.P. Richman, J. Hurley, et al.
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control
Cancer, 94 (2002), pp. 2295-2304
33
C.R. Green
Ethics. The quality of cancer pain management for racial and ethnic minority Americans: unequal burdens and unheard voices
Journal of Cancer Pain & Symptom Palliation, 2 (2006), pp. 19-27
34
M. van den Beuken-van Everdingen, J. de Rijke, A. Kessels, H. Schouten, M. van Kleef, J. Patijn
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
Annals of Oncology, 18 (2007), pp. 1437-1449
35
S.Y.C. Lee, C.H.J. Wang
Assessing the Need for Supportive Care Need and Cancer Pain
National Taipei University of Nursing and Health Science, Taipei, Taiwan (2015)
Article  
36
D. Osoba, H. Ming-Ann, C. Copley-Merriman, et al.
Stated Preferences of Patients with Cancer for Health-related Quality-of-life (HRQOL) Domains During Treatment
Quality of Life Research, 15 (2006), pp. 273-283
37
S.Y.C. Lee, M.F. Hou, S.H. Shieh, R.K. Hsieh, K.C. Lin, S.C. Chen
Supportive Care Needs in Cancer Survivors: A Triangulation Study Taipei, Taiwan
National Taipei University of Nursing and Health Science (2013)
Article  
38
S.L. Beck, G.L. Towsley, M.S. Caserta, K. Lindau, W.N. Dudley
Symptom experiences and quality of life of rural and urban older adult cancer survivors
Cancer Nursing, 32 (2009), pp. 359-369
39
National Cancer Institute. Cancer Survivorshp Research: Cancer Survivor Definition.
Available from URL: http://cancercontrol.cancer.gov/ocs/definitions.html [accessed Sep., 21, 2011].
Article  
40
A.E. Lowery, T. Starr, L.K. Dhingra, et al.
Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment
Pain Medicine (Malden, Mass.), 14 (2013), pp. 1673-1680
41
A. Sánchez-Jiménez, I. Cantarero-Villanueva, R. Molina-Barea, C. Fernández-Lao, N. Galiano-Castillo, M. Arroyo-Morales
Widespread Pressure Pain Hypersensitivity and Ultrasound Imaging Evaluation of Abdominal Area after Colon Cancer Treatment
Pain Medicine, 15 (2014), pp. 233-240
42
S.-D. Chung, J.J. Keller, H.-C. Lin
A case-control study of chronic prostatitis/chronic pelvic pain syndrome and colorectal cancer
BJU International, 110 (2012), pp. 550-554
43
J.C. Brown, J.J. Mao, C. Stricker, W.-T. Hwang, K.-S. Tan, K.H. Schmitz
Aromatase Inhibitor Associated Musculoskeletal Symptoms are associated with Reduced Physical Activity among Breast Cancer Survivors
Breast Journal, 20 (2014), pp. 22-28
44
O. Singer, T. Cigler, A.B. Moore, et al.
Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study
Arthritis Care Res (Hoboken), 64 (2012), pp. 1910-1918
45
C. Kannie, S.X. Xie, C.T. Stricker, et al.
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
BMC Cancer, 13 (2013), pp. 1-7
Article  
46
K.M. Kidwell, S.E. Harte, D.F. Hayes, et al.
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy
Cancer (0008543X), 120 (2014), pp. 2403-2411
47
M.I. Bennett, C. Rayment, M. Hjermstad, N. Aass, A. Caraceni, S. Kaasa
Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review
Pain, 153 (2012), pp. 359-365
48
C. Tofthagen, S.C. McMillan
Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer
Cancer Nursing, 33 (2010), pp. 436-444
49
V. Piano, S. Verhagen, A. Schalkwijk, et al.
Diagnosing Neuropathic Pain in Patients with Cancer: Comparative Analysis of Recommendations in National Guidelines from European Countries
Pain Practice, 13 (2013), pp. 433-439
50
I. Cantarero-Villanueva, C. Fernández-Lao, E. Caro-Morán, et al.
Aquatic exercise in a chest-high pool for hormone therapy-induced arthralgia in breast cancer survivors: a pragmatic controlled trial
Clinical Rehabilitation, 27 (2013), pp. 123-132
51
I. Cantarero-Villanueva, C. Fernández-Lao, C. Fernández-De-Las-Peñas, et al.
Effectiveness of Water Physical Therapy on Pain, Pressure Pain Sensitivity, and Myofascial Trigger Points in Breast Cancer Survivors: A Randomized, Controlled Clinical Trial
Pain Medicine, 13 (2012), pp. 1509-1519
52
A.L. Cheville, J.R. Basford
Role of rehabilitation medicine and physical agents in the treatment of cancer-associated pain
Journal of Clinical Oncology, 32 (2014), pp. 1691-1702
53
D. Hui, E. Bruera
A personalized approach to assessing and managing pain in patients with cancer
Journal of Clinical Oncology, 32 (2014), pp. 1640-1646
54
C. Wrosch, C.M. Sabiston
Goal adjustment, physical and sedentary activity, and well-being and health among breast cancer survivors
Psycho-Oncology, 22 (2013), pp. 581-589

References

Close